Alcon, a Novartis Company
Quick facts
Marketed products
- Subject's habitual PGA monotherapy · Ophthalmology
PGA (prostaglandin analog) monotherapy reduces intraocular pressure by increasing uveoscleral outflow of aqueous humor.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: